Evidence map›Paper›PMID 41803396›Full record

ArticleScientific reports2026

The association between serum follicle-stimulating hormone and luteinizing hormone levels and congestive heart failure in postmenopausal women: a cross-sectional study.

Hangyu Zhou, Saiyaremu Xierzhati, Diliyaer Adili, Tingting Wang, Tiantian Wang, Zhao Wang, Wenzheng Zhou, Jie Li

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hangyu Zhou *The Cardiac and Panvascular Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China.
Saiyaremu Xierzhati *The Cardiac and Panvascular Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China.
Diliyaer AdiliThe Cardiac and Panvascular Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China.
Tingting WangThe Cardiac and Panvascular Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China.
Tiantian WangThe Cardiac and Panvascular Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China.
Zhao WangThe Cardiac and Panvascular Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China. xjzzqwz@163.com.
Wenzheng ZhouDepartment of Orthopaedics, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830000, China. 1975255404@qq.com.
Jie LiThe Cardiac and Panvascular Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China. lijie090715@126.com.

Funding

the Natural Science Foundation of Xinjiang Uygur Autonomous Region 2025D01C154
6 · The paper itself

Abstract

This study aims to explore the relationship between follicle-stimulating hormone (FSH) levels, serum luteinizing hormone (LH) levels, and the risk of congestive heart failure (CHF) in postmenopausal women. While earlier investigations have looked into the possible connection between serum sex hormones and heart health, the results have not provided clear conclusions. This study included a total of 2,853 postmenopausal women who visited the People’s Hospital of Xinjiang Uygur Autonomous Region. The associations between FSH, LH, and CHF were explored through univariate and multivariate logistic regression analyses. To analyze the dose-response relationship, a generalized additive model (GAM) was utilized. Additionally, sensitivity analysis, mediation analysis, and subgroup analysis were performed to confirm the reliability of these findings. The discriminatory ability of FSH and LH for distinguishing CHF was assessed using the area under the curve (AUC). Their incremental value was further evaluated with continuous net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Clinical utility was examined using decision curve analysis (DCA). Findings from the comprehensive logistic regression analysis indicated a notable inverse relationship between FSH and LH levels and the occurrence of CHF. The odds ratios (OR) [95% confidence intervals (CI)] corresponding to each standard deviation increase in FSH and LH were 0.75 (0.67 ~ 0.85) and 0.88 (0.78 ~ 0.99), respectively. The GAM identified critical thresholds for FSH and LH. When FSH was below 69.21 mIU/mL, each increase of one standard deviation was associated with a 36% reduction in the risk of HF, OR: 0.64 (0.52–0.78). When LH levels were below 26.49 mIU/mL, each increase of one standard deviation was associated with a 40% reduction in the risk of HF, OR: 0.60 (0.45–0.80). Sensitivity analysis and subgroup analysis both confirmed robustness. Mediation analysis revealed that the association between LH and heart failure was influenced by estrogen and progesterone, whereas FSH was not mediated by these hormones. In summary, this research uncovers a complex relationship between the levels of FSH and LH and the occurrence of CHF in women after menopause. These results emphasize the critical role of hormonal balance in the cardiovascular well-being of postmenopausal females, shedding light on the connection between gonadotropins and CHF. These findings could inform future approaches to the prevention and management of CHF, while also stressing the necessity for extensive prospective studies to confirm these findings and investigate their potential clinical significance.

Indexed as

Follicle Stimulating HormoneHeart FailureLuteinizing HormonePostmenopauseAgedCross-Sectional StudiesFemaleHumansMiddle AgedFollicle Stimulating HormoneLuteinizing HormoneCongestive heart failureFollicle-stimulating hormoneLuteinizing hormonePostmenopausal women

Identifiers

PMID41803396
PMCPMC13096550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.